[Dyslipidaemia and atherogenic risk in patients with systemic lupus erythematosus]

José Antonio de Jesús Batún Garrido1, Hugo Alberto Radillo Alba1, Éufrates Hernández Núñez2

  • 1Residente de tercer año de Medicina Interna, Hospital Regional de Alta Especialidad Dr. Gustavo A. Rovirosa Pérez, Villahermosa , Tabasco, México.

Medicina Clinica
|May 21, 2016
PubMed

Insights

Systemic lupus erythematosus patients often have dyslipidaemia, increasing cardiovascular risk. Higher disease activity and prednisone use are linked to dyslipidaemia, while hydroxychloroquine may be protective.

Area of Science:

  • Rheumatology
  • Cardiology
  • Metabolic Disorders

Background:

  • Dyslipidaemia is a frequent comorbidity in patients diagnosed with systemic lupus erythematosus (SLE).
  • This comorbidity contributes significantly to the overall health burden and cardiovascular risk in SLE patients.

Purpose of the Study:

  • To investigate the prevalence of dyslipidaemia in SLE patients.
  • To identify clinical and therapeutic factors associated with dyslipidaemia in this population.
  • To assess the atherogenic risk in SLE patients.

Main Methods:

  • A cohort of 51 patients with systemic lupus erythematosus was analyzed.
  • Data collected included disease variables, medication use, and calculated atherogenic risk indices.
  • Statistical analyses, including Chi square, ANOVA, and logistic regression, were employed to determine associations.

Main Results:

  • A high prevalence of dyslipidaemia was observed in 68.6% of the patients.
  • Significant associations were found between dyslipidaemia and disease activity (SLEDAI), lupus nephritis, and prednisone use (≥20mg/day).
  • Conversely, hydroxychloroquine use showed a significant association with the absence of dyslipidaemia.

Conclusions:

  • Patients with SLE exhibit a high prevalence of dyslipidaemia and elevated atherogenic risk.
  • Factors such as high disease activity (SLEDAI≥4) and significant prednisone use are independently associated with increased dyslipidaemia.
  • These findings underscore the heightened cardiovascular risk in SLE patients and highlight potential therapeutic targets.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
569
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
783
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.6K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K